These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 11996958

  • 1. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.
    Rahmani M, Raiszadeh F, Allahverdian S, Kiaii S, Navab M, Azizi F.
    Atherosclerosis; 2002 Jun; 162(2):381-9. PubMed ID: 11996958
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
    Kim HK, Chang SA, Choi EK, Kim YJ, Kim HS, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS.
    Int J Cardiol; 2005 Jun 08; 101(3):435-40. PubMed ID: 15907412
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.
    Westerveld HT, van Lennep JE, van Lennep HW, Liem AH, de Boo JA, van der Schouw YT, Erkelens DW.
    Arterioscler Thromb Vasc Biol; 1998 Jul 08; 18(7):1101-7. PubMed ID: 9672070
    [Abstract] [Full Text] [Related]

  • 5. Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose tolerance.
    Fujiwara R, Kutsumi Y, Hayashi T, Nishio H, Koshino Y, Shimada Y, Nakai T, Miyabo S.
    Am J Cardiol; 1995 Jan 15; 75(2):122-6. PubMed ID: 7810485
    [Abstract] [Full Text] [Related]

  • 6. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY, Gümüşlü S, Semiz E.
    Clin Cardiol; 2004 Jul 15; 27(7):426-30. PubMed ID: 15298047
    [Abstract] [Full Text] [Related]

  • 7. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
    Rasouli M, Kiasari AM, Mokhberi V.
    Clin Chem Lab Med; 2006 Jul 15; 44(8):1015-21. PubMed ID: 16879071
    [Abstract] [Full Text] [Related]

  • 8. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
    Lehtonen A, Marniemi J, Inberg M, Maatela J, Alanen E, Niittymäki K.
    Atherosclerosis; 1986 Feb 15; 59(2):215-21. PubMed ID: 3083832
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lipid abnormalities in Greek patients with coronary artery disease.
    Elisaf MS, Siamopoulos KC, Tselegarides TJ, Bairaktari ETh, Goudevenos JA, Tselepis AD, Tsolas OE, Sideris DA.
    Int J Cardiol; 1997 Apr 18; 59(2):177-84. PubMed ID: 9158172
    [Abstract] [Full Text] [Related]

  • 11. Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians.
    Gupta R, Vasisht S, Bahl VK, Wasir HS.
    Int J Cardiol; 1996 Dec 13; 57(3):265-70. PubMed ID: 9024915
    [Abstract] [Full Text] [Related]

  • 12. Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk.
    van der Steeg WA, Boekholdt SM, Stein EA, El-Harchaoui K, Stroes ES, Sandhu MS, Wareham NJ, Jukema JW, Luben R, Zwinderman AH, Kastelein JJ, Khaw KT.
    Ann Intern Med; 2007 May 01; 146(9):640-8. PubMed ID: 17470832
    [Abstract] [Full Text] [Related]

  • 13. The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease.
    Paragh G, Seres I, Harangi M, Balogh Z, Illyés L, Boda J, Szilvássy Z, Kovács P.
    Diabetes Metab; 2003 Dec 01; 29(6):613-8. PubMed ID: 14707891
    [Abstract] [Full Text] [Related]

  • 14. HDL subparticles and coronary artery disease in NIDDM.
    O'Brien T, Nguyen TT, Hallaway BJ, Hodge D, Bailey K, Kottke BA.
    Atherosclerosis; 1996 Apr 05; 121(2):285-91. PubMed ID: 9125302
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Apo-B/apo-AI ratio: a better discriminator of coronary artery disease risk than other conventional lipid ratios in Indian patients with acute myocardial infarction.
    Goswami B, Rajappa M, Mallika V, Kumar S, Shukla DK.
    Acta Cardiol; 2008 Dec 05; 63(6):749-55. PubMed ID: 19157171
    [Abstract] [Full Text] [Related]

  • 17. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
    Baroni MG, Berni A, Romeo S, Arca M, Tesorio T, Sorropago G, Di Mario U, Galton DJ.
    BMC Med Genet; 2003 Sep 10; 4():8. PubMed ID: 12964943
    [Abstract] [Full Text] [Related]

  • 18. LDL molecular size as risk factor in coronary artery disease.
    Kozma L, Fodor J, Chockalingam A, Sussex B.
    Acta Med Hung; 2003 Sep 10; 49(1-2):65-77. PubMed ID: 1296188
    [Abstract] [Full Text] [Related]

  • 19. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.
    Boemi M, Leviev I, Sirolla C, Pieri C, Marra M, James RW.
    Atherosclerosis; 2001 Mar 10; 155(1):229-35. PubMed ID: 11223446
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of apolipoproteins A-I and B as markers of angiographically assessed coronary artery disease.
    Marcovina S, Zoppo A, Graziani MS, Vassanelli C, Catapano AL.
    Ric Clin Lab; 1988 Mar 10; 18(4):319-28. PubMed ID: 3150125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.